Academic Journal
Soluble ACE2 correlates with severe COVID-19 and can impair antibody responses
| Title: | Soluble ACE2 correlates with severe COVID-19 and can impair antibody responses |
|---|---|
| Authors: | Lebedin, M., Ratswohl, C., Garg, A., Schips, M., Vazquez Garcia, C., Spatt, L., Thibeault, C., Obermayer, B., Weiner, J., Moreno Velásquez, I., Gerhard, C., Stubbemann, P., Hanitsch, L.G., Pischon, T., Witzenrath, M., Sander, L.E., Kurth, F., Meyer-Hermann, M., de la Rosa, K. |
| Publisher Information: | Cell Press |
| Publication Year: | 2024 |
| Collection: | Max-Delbrueck-Center for Molecular Medicine, Berlin: MDC Repository |
| Subject Terms: | Cardiovascular and Metabolic Diseases, Cancer Research, Technology Platforms, Topic 3: Integrative Biomedicine |
| Description: | Identifying immune modulators that impact neutralizing antibody responses against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is of great relevance. We postulated that high serum concentrations of soluble angiotensin-converting enzyme 2 (sACE2) might mask the spike and interfere with antibody maturation toward the SARS-CoV-2-receptor-binding motif (RBM). We tested 717 longitudinal samples from 295 COVID-19 patients and showed a 2- to 10-fold increase of enzymatically active sACE2 (a-sACE2), with up to 1 μg/mL total sACE2 in moderate and severe patients. Fifty percent of COVID-19 sera inhibited ACE2 activity, in contrast to 1.3% of healthy donors and 4% of non-COVID-19 pneumonia patients. A mild inverse correlation of a-sACE2 with RBM-directed serum antibodies was observed. In silico, we show that sACE2 concentrations measured in COVID-19 sera can disrupt germinal center formation and inhibit timely production of high-affinity antibodies. We suggest that sACE2 is a biomarker for COVID-19 and that soluble receptors may contribute to immune suppression informing vaccine design. |
| Document Type: | article in journal/newspaper |
| File Description: | application/pdf; other |
| Language: | English |
| Relation: | https://edoc.mdc-berlin.de/id/eprint/24167/1/24167oa.pdf; https://edoc.mdc-berlin.de/id/eprint/24167/7/24167suppl.zip; Soluble ACE2 correlates with severe COVID-19 and can impair antibody responses. Lebedin, M., Ratswohl, C., Garg, A., Schips, M., Vazquez Garcia, C., Spatt, L., Thibeault, C., Obermayer, B., Weiner, J., Moreno Velásquez, I., Gerhard, C., Stubbemann, P., Hanitsch, L.G., Pischon, T., Witzenrath, M., Sander, L.E., Kurth, F., Meyer-Hermann, M. and de la Rosa, K. iScience 27 (3): 109330. 15 March 2024; PMID:38496296; https://doi.org/10.1016/j.isci.2024.109330 |
| DOI: | 10.1016/j.isci.2024.109330 |
| Availability: | https://edoc.mdc-berlin.de/id/eprint/24167/ https://edoc.mdc-berlin.de/24167/ https://doi.org/10.1016/j.isci.2024.109330 |
| Rights: | cc_by_nc_nd_4 |
| Accession Number: | edsbas.587F2C43 |
| Database: | BASE |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://edoc.mdc-berlin.de/id/eprint/24167/# Name: EDS - BASE (ns324271) Category: fullText Text: View record from BASE |
|---|---|
| Header | DbId: edsbas DbLabel: BASE An: edsbas.587F2C43 RelevancyScore: 950 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 949.707946777344 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Soluble ACE2 correlates with severe COVID-19 and can impair antibody responses – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Lebedin%2C+M%2E%22">Lebedin, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Ratswohl%2C+C%2E%22">Ratswohl, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Garg%2C+A%2E%22">Garg, A.</searchLink><br /><searchLink fieldCode="AR" term="%22Schips%2C+M%2E%22">Schips, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Vazquez+Garcia%2C+C%2E%22">Vazquez Garcia, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Spatt%2C+L%2E%22">Spatt, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Thibeault%2C+C%2E%22">Thibeault, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Obermayer%2C+B%2E%22">Obermayer, B.</searchLink><br /><searchLink fieldCode="AR" term="%22Weiner%2C+J%2E%22">Weiner, J.</searchLink><br /><searchLink fieldCode="AR" term="%22Moreno+Velásquez%2C+I%2E%22">Moreno Velásquez, I.</searchLink><br /><searchLink fieldCode="AR" term="%22Gerhard%2C+C%2E%22">Gerhard, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Stubbemann%2C+P%2E%22">Stubbemann, P.</searchLink><br /><searchLink fieldCode="AR" term="%22Hanitsch%2C+L%2EG%2E%22">Hanitsch, L.G.</searchLink><br /><searchLink fieldCode="AR" term="%22Pischon%2C+T%2E%22">Pischon, T.</searchLink><br /><searchLink fieldCode="AR" term="%22Witzenrath%2C+M%2E%22">Witzenrath, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Sander%2C+L%2EE%2E%22">Sander, L.E.</searchLink><br /><searchLink fieldCode="AR" term="%22Kurth%2C+F%2E%22">Kurth, F.</searchLink><br /><searchLink fieldCode="AR" term="%22Meyer-Hermann%2C+M%2E%22">Meyer-Hermann, M.</searchLink><br /><searchLink fieldCode="AR" term="%22de+la+Rosa%2C+K%2E%22">de la Rosa, K.</searchLink> – Name: Publisher Label: Publisher Information Group: PubInfo Data: Cell Press – Name: DatePubCY Label: Publication Year Group: Date Data: 2024 – Name: Subset Label: Collection Group: HoldingsInfo Data: Max-Delbrueck-Center for Molecular Medicine, Berlin: MDC Repository – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Cardiovascular+and+Metabolic+Diseases%22">Cardiovascular and Metabolic Diseases</searchLink><br /><searchLink fieldCode="DE" term="%22Cancer+Research%22">Cancer Research</searchLink><br /><searchLink fieldCode="DE" term="%22Technology+Platforms%22">Technology Platforms</searchLink><br /><searchLink fieldCode="DE" term="%22Topic+3%3A+Integrative+Biomedicine%22">Topic 3: Integrative Biomedicine</searchLink> – Name: Abstract Label: Description Group: Ab Data: Identifying immune modulators that impact neutralizing antibody responses against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is of great relevance. We postulated that high serum concentrations of soluble angiotensin-converting enzyme 2 (sACE2) might mask the spike and interfere with antibody maturation toward the SARS-CoV-2-receptor-binding motif (RBM). We tested 717 longitudinal samples from 295 COVID-19 patients and showed a 2- to 10-fold increase of enzymatically active sACE2 (a-sACE2), with up to 1 μg/mL total sACE2 in moderate and severe patients. Fifty percent of COVID-19 sera inhibited ACE2 activity, in contrast to 1.3% of healthy donors and 4% of non-COVID-19 pneumonia patients. A mild inverse correlation of a-sACE2 with RBM-directed serum antibodies was observed. In silico, we show that sACE2 concentrations measured in COVID-19 sera can disrupt germinal center formation and inhibit timely production of high-affinity antibodies. We suggest that sACE2 is a biomarker for COVID-19 and that soluble receptors may contribute to immune suppression informing vaccine design. – Name: TypeDocument Label: Document Type Group: TypDoc Data: article in journal/newspaper – Name: Format Label: File Description Group: SrcInfo Data: application/pdf; other – Name: Language Label: Language Group: Lang Data: English – Name: NoteTitleSource Label: Relation Group: SrcInfo Data: https://edoc.mdc-berlin.de/id/eprint/24167/1/24167oa.pdf; https://edoc.mdc-berlin.de/id/eprint/24167/7/24167suppl.zip; Soluble ACE2 correlates with severe COVID-19 and can impair antibody responses. Lebedin, M., Ratswohl, C., Garg, A., Schips, M., Vazquez Garcia, C., Spatt, L., Thibeault, C., Obermayer, B., Weiner, J., Moreno Velásquez, I., Gerhard, C., Stubbemann, P., Hanitsch, L.G., Pischon, T., Witzenrath, M., Sander, L.E., Kurth, F., Meyer-Hermann, M. and de la Rosa, K. iScience 27 (3): 109330. 15 March 2024; PMID:38496296; https://doi.org/10.1016/j.isci.2024.109330 – Name: DOI Label: DOI Group: ID Data: 10.1016/j.isci.2024.109330 – Name: URL Label: Availability Group: URL Data: https://edoc.mdc-berlin.de/id/eprint/24167/<br />https://edoc.mdc-berlin.de/24167/<br />https://doi.org/10.1016/j.isci.2024.109330 – Name: Copyright Label: Rights Group: Cpyrght Data: cc_by_nc_nd_4 – Name: AN Label: Accession Number Group: ID Data: edsbas.587F2C43 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsbas&AN=edsbas.587F2C43 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.isci.2024.109330 Languages: – Text: English Subjects: – SubjectFull: Cardiovascular and Metabolic Diseases Type: general – SubjectFull: Cancer Research Type: general – SubjectFull: Technology Platforms Type: general – SubjectFull: Topic 3: Integrative Biomedicine Type: general Titles: – TitleFull: Soluble ACE2 correlates with severe COVID-19 and can impair antibody responses Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lebedin, M. – PersonEntity: Name: NameFull: Ratswohl, C. – PersonEntity: Name: NameFull: Garg, A. – PersonEntity: Name: NameFull: Schips, M. – PersonEntity: Name: NameFull: Vazquez Garcia, C. – PersonEntity: Name: NameFull: Spatt, L. – PersonEntity: Name: NameFull: Thibeault, C. – PersonEntity: Name: NameFull: Obermayer, B. – PersonEntity: Name: NameFull: Weiner, J. – PersonEntity: Name: NameFull: Moreno Velásquez, I. – PersonEntity: Name: NameFull: Gerhard, C. – PersonEntity: Name: NameFull: Stubbemann, P. – PersonEntity: Name: NameFull: Hanitsch, L.G. – PersonEntity: Name: NameFull: Pischon, T. – PersonEntity: Name: NameFull: Witzenrath, M. – PersonEntity: Name: NameFull: Sander, L.E. – PersonEntity: Name: NameFull: Kurth, F. – PersonEntity: Name: NameFull: Meyer-Hermann, M. – PersonEntity: Name: NameFull: de la Rosa, K. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Type: published Y: 2024 Identifiers: – Type: issn-locals Value: edsbas – Type: issn-locals Value: edsbas.oa |
| ResultId | 1 |